Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent

Amphadase (formulated as a replacement for Wydase which was discontinued in 2001) contains hyaluronidase, an enzyme that breaks down hyaluronic acid in connective tissue, increasing tissue permeability. Hyaluronidase is typically used as an adjunctive agent to facilitate the dispersion and absorption of other drugs.

Latest FDA Drug Approvals...

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals